We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

46 hedge funds and large institutions have $33.6M invested in TG Therapeutics in 2013 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 6

188% more capital invested

Capital invested by funds: $11.7M → $33.6M (+$21.9M)

143% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 7

28% more funds holding

Funds holding: 36 → 46 (+10)

Holders
46
Holders Change
+10
Holders Change %
+27.78%
% of All Funds
1.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
18
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BM
Bridger Management
New York
+$9.17M
2
Jennison Associates
Jennison Associates
New York
+$5.33M
3
BBA
Baker Bros. Advisors
New York
+$3.67M
4
RCM
RA Capital Management
Massachusetts
+$3.67M
5
SM
Sabby Management
Florida
+$1.68M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$724K
2
Morgan Stanley
Morgan Stanley
New York
-$211K
3
Jane Street
Jane Street
New York
-$155K
4
NI
Numeric Investors
Massachusetts
-$122K
5
Bank of America
Bank of America
North Carolina
-$97.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
1
Jennison Associates
New York
$7.83M +$5.33M +871,432 +131%
BM
2
Bridger Management
New York
$7.56M +$9.17M +1,500,000 New
BBA
3
Baker Bros. Advisors
New York
$3.02M +$3.67M +600,000 New
RCM
4
RA Capital Management
Massachusetts
$3.02M +$3.67M +600,000 New
BFA
5
BlackRock Fund Advisors
California
$2.23M +$940K +153,719 +53%
SM
6
Sabby Management
Florida
$1.4M +$1.68M +275,479 New
Northern Trust
7
Northern Trust
Illinois
$1.02M +$818K +133,775 +194%
Millennium Management
8
Millennium Management
New York
$856K +$1.04M +169,749 New
BIT
9
BlackRock Institutional Trust
California
$823K +$233K +38,038 +30%
State Street
10
State Street
Massachusetts
$793K +$598K +97,833 +169%
Neuberger Berman Group
11
Neuberger Berman Group
New York
$636K +$772K +126,200 New
SM
12
Scoggin Management
New York
$445K +$540K +88,351 New
Geode Capital Management
13
Geode Capital Management
Massachusetts
$441K +$415K +67,814 +361%
Vanguard Group
14
Vanguard Group
Pennsylvania
$397K +$308K +50,321 +182%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$379K +$64.4K +10,535 +16%
DCM
16
DAFNA Capital Management
California
$378K +$459K +75,000 New
TCIM
17
TIAA CREF Investment Management
New York
$330K -$79.2K -12,959 -17%
Fidelity Investments
18
Fidelity Investments
Massachusetts
$222K +$267K +43,600 New
BIM
19
BlackRock Investment Management
Delaware
$213K +$74.5K +12,182 +40%
California Public Employees Retirement System
20
California Public Employees Retirement System
California
$189K +$227K +37,200 New
SIP
21
Stoneridge Investment Partners
Pennsylvania
$162K +$197K +32,142 New
WC
22
Wexford Capital
Florida
$151K -$61.2K -10,000 -25%
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$142K +$34.2K +5,600 +25%
TA
24
Teachers Advisors
New York
$108K +$24.6K +4,021 +23%
Charles Schwab
25
Charles Schwab
California
$94K – – –
1
2 3

TGTX Hedge Fund Activity: Q3 2013 in Review

46 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q3 2013, worth a combined $33.6M — up 188% from $11.7M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new TGTX positions and 7 closed out — a net gain of 10 holders — while 18 added to existing stakes and 6 trimmed.

The largest buyer was Bridger Management, opening a new position worth an estimated $9.17M. The largest seller was Goldman Sachs, exiting entirely with an estimated $724K sold.

  • 46 institutional investors held TG Therapeutics (TGTX) as of Q3 2013, up from 36 in Q2 2013.
  • Funds reported $33.6M of TG Therapeutics stock for Q3 2013, up 188% quarter-over-quarter.
  • 17 funds opened new TG Therapeutics positions in Q3 2013 and 7 closed out, a net change of +10 holders.
  • The largest TG Therapeutics buyer in Q3 2013 was Bridger Management, an estimated $9.17M added.
  • The largest TG Therapeutics seller in Q3 2013 was Goldman Sachs, an estimated $724K sold.

Based on aggregated 13F filings for Q3 2013.